Article info

Download PDFPDF
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

Authors

  1. Correspondence to Dr Yolanda Garcia Garcia, Oncología Médica, Parc Taulí Hospital Universitari, Sabadell 08208, Spain; ygarcia{at}tauli.cat
View Full Text

Citation

Garcia Garcia Y, de Juan Ferré A, Mendiola C, et al
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

Publication history

  • Received January 24, 2019
  • Revision received May 20, 2019
  • Accepted May 23, 2019
  • First published July 1, 2019.
Online issue publication 
July 01, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.